Lonza Group Ltd Stock Other OTC
Equities
LZAGY
US54338V1017
Biotechnology & Medical Research
Sales 2024 * | 6.66B 7.4B 10.06B | Sales 2025 * | 7.62B 8.47B 11.51B | Capitalization | 38.38B 42.63B 57.97B |
---|---|---|---|---|---|
Net income 2024 * | 886M 984M 1.34B | Net income 2025 * | 1.1B 1.22B 1.66B | EV / Sales 2024 * | 6.18 x |
Net Debt 2024 * | 2.79B 3.1B 4.21B | Net Debt 2025 * | 3.4B 3.78B 5.13B | EV / Sales 2025 * | 5.48 x |
P/E ratio 2024 * |
43.4
x | P/E ratio 2025 * |
34.6
x | Employees | - |
Yield 2024 * |
0.85% | Yield 2025 * |
0.98% | Free-Float | 95.87% |
Latest transcript on Lonza Group Ltd
Managers | Title | Age | Since |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 17-04-24 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 21-11-30 |
Maria Nunez
COO | Chief Operating Officer | 55 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 14-04-15 |
Director/Board Member | 66 | 14-04-15 | |
Marion Helmes
BRD | Director/Board Member | 58 | 22-05-04 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B | |
+24.01% | 11.97B |